Hemispherx Biopharma, Inc. (AIM)

Last Three Months

20-Jan-24 -- 19-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

15

0

4

+1

0

+2

0

+3

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
18-Mar-24 3:01 PM View:	15-Mar-24 Private Purchase $30.00K	Appelrouth Stewart Director		Hemispherx Biopharma, Inc. - AIM	61% 148.85K to 239.76K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 3:01 PM View:	15-Mar-24 Private Purchase $25.00K	Equels Thomas K. CEO & President Director		Hemispherx Biopharma, Inc. - AIM	12% 640.7K to 716.46K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 3:01 PM View:	15-Mar-24 Private Purchase $12.50K	Rodino Peter W. III COO, Secretary, Gen. Counsel		Hemispherx Biopharma, Inc. - AIM	26% 143.84K to 181.72K	0	0	--	--	Show Txns Hide Txns

22-Mar-24 1:30 PM View:	21-Mar-24 Private Purchase $15.00K	Bryan Nancy Director		Hemispherx Biopharma, Inc. - AIM	100% 0 to 38.46K	0	0	--	--	Show Txns Hide Txns